Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy.
Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S. Diamand R, et al. Among authors: chiacchio g. World J Urol. 2023 Jan;41(1):77-84. doi: 10.1007/s00345-022-04244-4. Epub 2022 Dec 12. World J Urol. 2023. PMID: 36509932
External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Diamand R, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Favre MM, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Peltier A, Albisinni S. Diamand R, et al. Among authors: chiacchio g. Eur Urol Focus. 2023 Mar;9(2):309-316. doi: 10.1016/j.euf.2022.09.006. Epub 2022 Sep 21. Eur Urol Focus. 2023. PMID: 36153227
Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?
Diamand R, Albisinni S, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, An Nguyen T, Fournier G, Fiard G, Ploussard G, Peltier A, Roumeguère T. Diamand R, et al. Among authors: chiacchio g. Eur Urol Focus. 2023 Mar;9(2):298-302. doi: 10.1016/j.euf.2022.09.011. Epub 2022 Oct 6. Eur Urol Focus. 2023. PMID: 36210296
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.
Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S. Diamand R, et al. Among authors: chiacchio g. Prostate. 2023 May;83(6):572-579. doi: 10.1002/pros.24490. Epub 2023 Jan 27. Prostate. 2023. PMID: 36705314
Radiomics vs radiologist in prostate cancer. Results from a systematic review.
Chiacchio G, Castellani D, Nedbal C, De Stefano V, Brocca C, Tramanzoli P, Galosi AB, Donalisio da Silva R, Teoh JY, Tiong HY, Naik N, Somani BK, Merseburger AS, Gauhar V. Chiacchio G, et al. World J Urol. 2023 Mar;41(3):709-724. doi: 10.1007/s00345-023-04305-2. Epub 2023 Mar 3. World J Urol. 2023. PMID: 36867239 Review.
A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study.
Mjaess G, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S, Diamand R. Mjaess G, et al. Among authors: chiacchio g. Eur Urol Focus. 2023 Nov;9(6):992-999. doi: 10.1016/j.euf.2023.04.008. Epub 2023 May 3. Eur Urol Focus. 2023. PMID: 37147167
Reply to May et al. The Goal of Achieving High-Quality Surgical First-Line Therapy in Patients with Penile Cancer Is Important; However, Some Collective Efforts Are Still Required in Order to Reach It. Comment on "Brassetti et al. Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The Tetrafecta Achievement. Curr. Oncol. 2023, 30, 1882-1892".
Chiacchio G, Brassetti A, Simone G. Chiacchio G, et al. Curr Oncol. 2023 Apr 21;30(4):4379-4381. doi: 10.3390/curroncol30040333. Curr Oncol. 2023. PMID: 37185446 Free PMC article.
Long-term oncologic and functional outcomes following robot-assisted radical cystectomy and intracorporeal Padua ileal bladder: results from a single high-volume center.
Tuderti G, Mastroianni R, Chiacchio G, Anceschi U, Bove AM, Brassetti A, Ferriero M, Misuraca L, Flammia RS, Proietti F, D'Annunzio S, Leonardo C, Guaglianone S, Anselmi M, Zampa A, Galosi AB, Torregiani G, Gallucci M, Simone G. Tuderti G, et al. Among authors: chiacchio g. World J Urol. 2023 Sep;41(9):2359-2366. doi: 10.1007/s00345-023-04523-8. Epub 2023 Jul 31. World J Urol. 2023. PMID: 37518504
Robotic Surgery in Urology: History from PROBOT® to HUGOTM.
Brassetti A, Ragusa A, Tedesco F, Prata F, Cacciatore L, Iannuzzi A, Bove AM, Anceschi U, Proietti F, D'Annunzio S, Flammia RS, Chiacchio G, Ferriero M, Guaglianone S, Mastroianni R, Misuraca L, Tuderti G, Simone G. Brassetti A, et al. Among authors: chiacchio g. Sensors (Basel). 2023 Aug 11;23(16):7104. doi: 10.3390/s23167104. Sensors (Basel). 2023. PMID: 37631641 Free PMC article. Review.
The Impact of Physical Activity on the Outcomes of Active Surveillance in Prostate Cancer Patients: A Scoping Review.
Brassetti A, Cacciatore L, Bove AM, Anceschi U, Proietti F, Misuraca L, Tuderti G, Flammia RS, Mastroianni R, Ferriero MC, Chiacchio G, D'Annunzio S, Pallares-Mendez R, Lombardo R, Leonardo C, De Nunzio C, Simone G. Brassetti A, et al. Among authors: chiacchio g. Cancers (Basel). 2024 Feb 1;16(3):630. doi: 10.3390/cancers16030630. Cancers (Basel). 2024. PMID: 38339381 Free PMC article. Review.
31 results